Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide)
Infection and Drug Resistance · 2025-09 · Volume 18 · 4901-4915
DOI: 10.2147/idr.s542287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2025-09. Verfasst von Mehdi Roshdi Maleki. Beteiligte Einrichtung: Department of Microbiology, Male.C., Islamic Azad University, Malekan, Iran. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Male.C., Islamic Azad University, Malekan, Iran.
ORCID-Profile: Mehdi Roshdi Maleki
Zitieren
APA
Roshdi Maleki, M. (2025). Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide). Infection and Drug Resistance, Volume 18, 4901-4915. https://doi.org/10.2147/idr.s542287
Vancouver
Roshdi Maleki M. Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide). Infection and Drug Resistance. 2025;Volume 18:4901-4915. doi:10.2147/idr.s542287
BibTeX
@article{RoshdiMaleki2025,
author = {Roshdi Maleki, Mehdi},
title = {Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide)},
journal = {Infection and Drug Resistance},
year = {2025},
volume = {Volume 18},
pages = {4901--4915},
doi = {10.2147/idr.s542287}
}
EUVIMED